Források
Minden oltásról:
https://pubmed.ncbi.nlm.nih.gov/12690795/
https://www.nature.com/articles/pr2007181
https://childrenshealthdefense.org/wp-content/uploads/2016/10/The-Simpsonwood-Documents.pdf
https://childrenshealthdefense.org/wp-content/uploads/safeminds-generation-zero.pdf
https://www.govinfo.gov/content/pkg/CHRG-106hhrg72722/html/CHRG-106hhrg72722.htm
http://www.oltasbiztonsag.hu/?pid=121
http://www.oltasbiztonsag.hu/?Gyermekkori-v%E9d%F5olt%E1sok&pid=24
0-4 hetes korban: BCG
2 hónapos korban: DPTa-IPV-HiB+PCV13
3 hónapos korban: DPTa-IPV-HiB
4 hónapos korban: DPTa-IPV-HiB+PCV13
12 hónapos korban: PCV13
15 hónapos korban: MMR
18 hónapos korban: DPTa-IPV-HiB
6 éves korban: DPTa-IPV
11 éves korban: MMR, dTap
12 éves korban: Hepatitis B
Minden oltás előbb-utóbb génterápia:
https://www.nature.com/articles/s41434-020-00204-y
https://share.baptisthealth.com/mrna-vaccines-vs-sarna-vaccines/
https://www.campfire.wiki/doku.php?id=covid-19_pandemic:timeline&s[]=genetics
https://www.tga.gov.au/sites/default/files/foi-2183-09.pdf
https://www.tga.gov.au/sites/default/files/foi-2183-09.pdf
https://www.nature.com/articles/s41434-020-00204-y
https://doi.org/10.1038/s41434-020-00204-y.
Kääriäinen L, Ahola T. Functions of alphavirus nonstructural proteins in RNA replication. Prog Nucleic Acid Res Mol Biol. 2002;71:187–222.
Maruggi, G., Ulmer, J. B., Rappuoli, R., & Yu, D. (2021). Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action. Current topics in microbiology and immunology, 10.1007/82_2021_233. Advance online publication. https://doi.org/10.1007/82_2021_233.
Brito, L. A., Kommareddy, S., Maione, D., Uematsu, Y., Giovani, C., Berlanda Scorza, F., Otten, G. R., Yu, D., Mandl, C. W., Mason, P. W., Dormitzer, P. R., Ulmer, J. B., & Geall, A. J. (2015). Self-amplifying mRNA vaccines. Advances in genetics, 89, 179–233. https://doi.org/10.1016.
Geall, A. J., Verma, A., Otten, G. R., Shaw, C. A., Hekele, A., Banerjee, K., Cu, Y., Beard, C. W., Brito, L. A., Krucker, T., O'Hagan, D. T., Singh, M., Mason, P. W., Valiante, N. M., Dormitzer, P. R., Barnett, S. W., Rappuoli, R., Ulmer, J. B., & Mandl, C. W. (2012). Nonviral delivery of self-amplifying RNA vaccines.
McKay, P. F., Hu, K., Blakney, A. K., Samnuan, K., Brown, J. C., Penn, R., Zhou, J., Bouton, C. R., Rogers, P., Polra, K., Lin, P., Barbosa, C., Tam, Y. K., Barclay, W. S., & Shattock, R. J. (2020). Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice. Nature communications, 11(1), 3523. https://doi.org/10.1038/s41467-020-17409-9. (Notice the conflicts here.)
Ballesteros-Briones, M. C., Silva-Pilipich, N., Herrador-Cañete, G., Vanrell, L., & Smerdou, C. (2020). A new generation of vaccines based on alphavirus self-amplifying RNA. Current opinion in virology, 44, 145–153. https://doi.org/10.1016/j.coviro.2020.08.003.
Blakney, A. K., McKay, P. F., Hu, K., Samnuan, K., Jain, N., Brown, A., Thomas, A., Rogers, P., Polra, K., Sallah, H., Yeow, J., Zhu, Y., Stevens, M. M., Geall, A., & Shattock, R. J. (2021). Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines. Journal of controlled release : official journal of the Controlled Release Society, 338, 201–210. https://doi.org/10.1016/j.jconrel.2021.08.029. (Notice the conflicts here.)
Lundstrom K. (2020). Self-Amplifying RNA Viruses as RNA Vaccines. International journal of molecular sciences, 21(14), 5130. https://doi.org/10.3390/ijms21145130.
https://clinicaltrials.gov/ct2/show/study/NCT04380701
https://www.tga.gov.au/sites/default/files/foi-2183-09.pdf
https://www.facebook.com/pharmacoidea/photos/a.144209155595949/6169585926391545
Maszkok veszélyesek:
https://www.facebook.com/pharmacoidea/photos/a.144209155595949/6118111764872295
Share this post